Apr 30, 2026 07:00AM
Feb 26, 2026 07:00AM
Feb 12, 2026 07:12AM
Feb 11, 2026 05:54PM
Feb 11, 2026 05:54PM
Jan 12, 2026 07:01AM
Jan 12, 2026 07:00AM Novocure Announces Preliminary Full Year and Fourth Quarter 2025 Performance and Provides Company Update
Oct 30, 2025 07:00AM
Sep 29, 2025 04:30PM
Sep 29, 2025 04:30PM
Aug 20, 2025 07:01AM
Aug 20, 2025 07:00AM
Jul 24, 2025 07:00AM
Jul 1, 2025 07:00AM Novocure to Present Final Secondary Endpoint Data from the Phase 3 PANOVA-3 Trial of Tumor Treating Fields (TTFields) in Pancreatic Cancer at the ESMO Gastrointestinal Cancers Congress 2025
May 31, 2025 03:08PM
May 31, 2025 08:00AM
Apr 25, 2025 06:54AM
Apr 24, 2025 07:00AM
Apr 22, 2025 07:12AM
Apr 22, 2025 07:09AM
Feb 27, 2025 07:00AM Novocure Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Company Update
Jan 13, 2025 07:06AM
Jan 13, 2025 07:00AM
Nov 21, 2024 07:01AM
Nov 21, 2024 07:00AM
Oct 30, 2024 07:00AM
Oct 16, 2024 06:06AM
Oct 15, 2024 04:44PM Novocure (NVCR) Announces FDA Approval of Optune Lua for the Treatment of Metastatic Non-Small Cell Lung Cancer
Oct 15, 2024 04:43PM
Oct 15, 2024 04:36PM
Oct 15, 2024 04:09PM
May 3, 2024 06:48AM
May 2, 2024 04:48PM
May 2, 2024 07:00AM
Mar 27, 2024 11:47AM NovoCure Ltd. (NVCR) PT Raised to $24 at H.C. Wainwright following positive METIS data
Feb 22, 2024 07:00AM
Jan 18, 2024 07:00AM
Jan 18, 2024 07:00AM
Jan 8, 2024 07:00AM
Nov 10, 2023 08:00AM
Oct 26, 2023 07:00AM
Aug 30, 2023 05:51AM Novocure (NVCR) Reports Publication of Primary Data from Phase 3 LUNAR Trial
Aug 29, 2023 06:31PM
Jul 31, 2023 08:25PM
Jul 27, 2023 07:00AM
Jul 22, 2023 09:30AM
Jul 3, 2023 09:00AM
Jun 29, 2023 09:00AM
Jun 6, 2023 08:07AM Zai Lab (ZLAB) and Novocure (NVCR) Report LUNAR Phase 3 Trial Demonstrates Statistically Significant and Clinically Meaningful Extension in Overall Survival
Jun 6, 2023 08:05AM

323,580 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All